2.要約中間連結財務諸表及び主な注記

(1)要約中間連結純損益及びその他の包括利益計算書

 

 

(単位:百万円)

 

 前中間連結会計期間

(自 2024年4月1日

 至 2024年9月30日)

 当中間連結会計期間

(自 2025年4月1日

 至 2025年9月30日)

売上収益

146,404

137,879

売上原価

63,507

60,679

売上総利益

82,897

77,200

販売費及び一般管理費

42,214

42,516

研究開発費

10,944

12,371

製品に係る無形資産償却費

4,505

4,446

その他の収益

207

417

その他の費用

1,568

369

営業利益

23,873

17,915

金融収益

1,008

884

金融費用

1,043

1,164

税引前中間利益

23,839

17,634

法人所得税費用

5,135

3,780

中間利益

18,704

13,854

その他の包括利益

 

 

純損益に振り替えられない項目:

 

 

その他の包括利益を通じて公正価値で測定する金融資産の純変動

1,287

380

純損益に振り替えられる可能性のある項目:

 

 

在外営業活動体の換算差額

4,259

7,855

キャッシュ・フロー・ヘッジ

10

持分法適用会社におけるその他の包括利益に対する持分

148

その他の包括利益

5,683

8,235

中間包括利益合計

13,020

22,089

中間利益の帰属

 

 

親会社の所有者持分

18,772

13,940

非支配持分

68

86

中間利益

18,704

13,854

中間包括利益合計の帰属

 

 

親会社の所有者持分

13,058

22,188

非支配持分

38

99

中間包括利益合計

13,020

22,089

1株当たり中間利益

 

 

基本的1株当たり中間利益(円)

52.88

41.76

希薄化後1株当たり中間利益(円)

52.74

41.70

 

<コアベース>

コア営業利益

29,739

22,314

 

 

E0094945360参天製薬株式会社SANTEN PHARMACEUTICAL CO., LTD.四半期第7号参考様式 [IFRS](連結)(一般2Q)IFRStrueCTE2025-04-012025-09-30HY2026-03-312024-04-012024-09-302025-03-311falsefalsefalse453602025-04-012025-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-04-012025-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-04-012025-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-04-012025-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-09-30jpigp_cor:RetainedEarningsIFRSMember453602024-09-30jpigp_cor:TreasurySharesIFRSMember453602024-09-30jpigp_cor:CapitalSurplusIFRSMember453602024-09-30jpigp_cor:ShareCapitalIFRSMember453602024-04-012024-09-30jpigp_cor:NonControllingInterestsIFRSMember453602024-04-012024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-04-012024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602024-04-012024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-04-012024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602024-04-012024-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-04-012024-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-04-012024-09-30jpigp_cor:RetainedEarningsIFRSMember453602024-04-012024-09-30jpigp_cor:TreasurySharesIFRSMember453602024-04-012024-09-30jpigp_cor:CapitalSurplusIFRSMember453602024-04-012024-09-30jpigp_cor:ShareCapitalIFRSMember453602024-03-31jpigp_cor:NonControllingInterestsIFRSMember453602024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602024-03-31jpigp_cor:RetainedEarningsIFRSMember453602024-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602024-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-03-31jpigp_cor:TreasurySharesIFRSMember453602024-03-31jpigp_cor:CapitalSurplusIFRSMember453602024-03-31jpigp_cor:ShareCapitalIFRSMember453602025-09-30jpigp_cor:NonControllingInterestsIFRSMember453602025-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602025-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-09-30jpigp_cor:RetainedEarningsIFRSMember453602025-09-30jpigp_cor:TreasurySharesIFRSMember453602025-09-30jpigp_cor:CapitalSurplusIFRSMember453602025-09-30jpigp_cor:ShareCapitalIFRSMember453602025-04-012025-09-30jpigp_cor:NonControllingInterestsIFRSMember453602025-04-012025-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-03-31jpigp_cor:NonControllingInterestsIFRSMember453602025-04-012025-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-04-012025-09-30jpigp_cor:RetainedEarningsIFRSMember453602025-04-012025-09-30jpigp_cor:TreasurySharesIFRSMember453602025-04-012025-09-30jpigp_cor:CapitalSurplusIFRSMember453602025-04-012025-09-30jpigp_cor:ShareCapitalIFRSMember453602025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-03-31jpigp_cor:RetainedEarningsIFRSMember453602025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602025-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-03-31jpigp_cor:TreasurySharesIFRSMember453602025-03-31jpigp_cor:CapitalSurplusIFRSMember453602025-03-31jpigp_cor:ShareCapitalIFRSMember453602024-09-30jpigp_cor:NonControllingInterestsIFRSMember453602024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-04-012025-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602024-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602024-04-012024-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602024-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-11-06453602025-09-30453602025-03-31453602025-04-012025-09-30453602024-09-30453602024-04-012024-09-30453602024-03-31453602025-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602025-04-012025-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602024-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602024-04-012024-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602025-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602024-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure